Cargando…
Change of Circulating Vascular Endothelial Growth Factor Level and Reduction of Anhedonia Are Associated in Patients With Major Depressive Disorder Treated With Repetitive Transcranial Magnetic Stimulation
AIM: Vascular endothelial growth factor (VEGF) has been implicated in mediating the effect of antidepressant therapies as it plays a significant role in the neurogenesis. Anhedonia, an endophenotype of major depressive disorder (MDD), is related to the dorsolateral prefrontal cortex, the major focus...
Autores principales: | Elemery, Monika, Kiss, Szilvia, Dome, Peter, Pogany, Laszlo, Faludi, Gabor, Lazary, Judit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9193814/ https://www.ncbi.nlm.nih.gov/pubmed/35711587 http://dx.doi.org/10.3389/fpsyt.2022.806731 |
Ejemplares similares
-
Peripheral endocannabinoid serum level in association with repetitive transcranial magnetic stimulation (rTMS) treatment in patients with major depressive disorder
por: Lazary, Judit, et al.
Publicado: (2021) -
What is the link between the antidepressants, the transcranial magnetic stimulation and the peripheral vascular endothelial growth factor?
por: Lazáry, J., et al.
Publicado: (2022) -
Symptom improvement is associated with serum cytokine level change during RTMS tretament in patients with treatment resistant depression
por: Lazary, J., et al.
Publicado: (2021) -
Health Control Beliefs and Attitude Toward Treatment in Psychiatric and Non-Psychiatric Clinical Samples
por: Pogany, Laszlo, et al.
Publicado: (2021) -
Maternal bonding styles in smokers and non-smokers: a comparative study
por: Csala, Iren, et al.
Publicado: (2016)